Literature DB >> 12062880

Another view of therapy for cognition in schizophrenia.

William T Carpenter, James M Gold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12062880     DOI： 10.1016/s0006-3223(02)01399-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  25 in total

1.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

Review 2.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

3.  A few methodologic issues of note.

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

Review 4.  Antipsychotic drugs for first-episode schizophrenia: a comparative review.

Authors:  Kayvon Salimi; L Fredrik Jarskog; Jeffrey A Lieberman
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

5.  Principles of antipsychotic prescribing for policy makers, circa 2008. Translating knowledge to promote individualized treatment.

Authors:  Joseph Parks; Alan Radke; George Parker; May-Ellen Foti; Robert Eilers; Mary Diamond; Dale Svendsen; Rajiv Tandon
Journal:  Schizophr Bull       Date:  2008-04-02       Impact factor: 9.306

6.  Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.

Authors:  Rosa Ayesa-Arriola; Jose Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; Roberto Roiz-Santiáñez; Obdulia Martínez-García; Jose Sánchez-Moreno; Rafael Tabarés-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

Review 7.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

8.  Diminished orientation-specific surround suppression of visual processing in schizophrenia.

Authors:  Jong H Yoon; Ariel S Rokem; Michael A Silver; Michael J Minzenberg; Stefan Ursu; J Daniel Ragland; Cameron S Carter
Journal:  Schizophr Bull       Date:  2009-07-20       Impact factor: 9.306

9.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

10.  Cognitive efficacy of quetiapine and olanzapine in early-onset first-episode psychosis.

Authors:  Olalla Robles; Arantzazu Zabala; Igor Bombín; Mara Parellada; Dolores Moreno; Ana Ruiz-Sancho; Celso Arango
Journal:  Schizophr Bull       Date:  2009-08-25       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.